Wire · opportunities
Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 8 September 2026 · Fusion42 review
Abbott has received FDA approval for its TactiFlex™ Duo Ablation Catheter, a device combining pulsed field ablation and radiofrequency energy to treat complex atrial fibrillation cases with flexible, precision therapy. The approval is supported by positive clinical data from the FlexPulse IDE study and enhances Abbott's cardiac ablation technology portfolio.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it.
◆ ◆ The Wire takeaway
Physicians treating complex AFib gain a new flexible tool that blends two ablation methods, raising expectations for tailored therapies. You should prepare to engage cardiologists adapting to dual-energy ablation tech as the procedure grows commercially.
◆ Coverage
3 sources · 8 Sep 2026
◆ Related on Wire
◆ Topics